Most Read Articles
Dr. Maria Katrina Florcruz, 30 Nov 2015
Seven predominantly eczema loci possibly involved in increased risk for atopic march, two of which were previously unidentified, has been identified in a meta-analysis.
Dr. Joslyn Ngu, 07 Jan 2016

A recent study shows cefalexin is effective for treating uncomplicated cellulitis caused by streptococcal species and methicillin-susceptible Staphylococcus aureus (MSSA). [Mayo Clin Proc 2014;89(10):1436–1451]

15 Feb 2016
New drug applications approved by US FDA as of 1 - 15 Feb 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Oct 2010
This study determined the effects of pre-medication with a second generation antihistamine (cetirizine) in urticaria induced by weak COX-1 inhibitors.

Atopic Dermatitis and Hand Eczema: Targeting the Skin Barrier

11 Nov 2016
At the 7th Galderma Skin Day, leading dermatologists, Dr Najeeb Ahmad Mohd Safdar of Hospital Tuanku Ja’afar, Seremban and Dr Derrick Aw of the National University Hospital, Singapore, presented on managing atopic dermatitis and hand eczema, with a special focus on Cetaphil® Restoraderm (Galderma) and the newly launched Nutraplus® (Galderma).

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
Dr. Maria Katrina Florcruz, 30 Nov 2015
Seven predominantly eczema loci possibly involved in increased risk for atopic march, two of which were previously unidentified, has been identified in a meta-analysis.
Dr. Joslyn Ngu, 07 Jan 2016

A recent study shows cefalexin is effective for treating uncomplicated cellulitis caused by streptococcal species and methicillin-susceptible Staphylococcus aureus (MSSA). [Mayo Clin Proc 2014;89(10):1436–1451]

15 Feb 2016
New drug applications approved by US FDA as of 1 - 15 Feb 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
01 Oct 2010
This study determined the effects of pre-medication with a second generation antihistamine (cetirizine) in urticaria induced by weak COX-1 inhibitors.